Unlike the Medicare Part D coverage exclusion, the Medicaid exclusion is permissive: States may, but do not have to, exclude “agents used for weight loss” from coverage. As of August 2024, 13 state ...
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...
President Joe Biden wants Medicare and Medicaid to cover weight-loss drugs, a proposal that would expand access to the costly ...
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...
He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...
The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling with obesity, not just as a treatment for diabetes. But because that rule ...
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...
From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? While there are some state and federal efforts to expand insurance coverage for these drugs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback